NCT02755298View on ClinicalTrials.gov

Chronic Clinical Effect of Acetazolamide

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Hypertension, Pulmonary
Interventions
DRUG

Acetazolamide

DRUG

Placebo

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT02755298 - Chronic Clinical Effect of Acetazolamide | Biotech Hunter | Biotech Hunter